title: Hepatitis E virus antibodies in patients with chronic liver disease.
abstract: In the United States, the seroprevalence rate for hepatitis E virus (HEV) is approximately 20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases significantly with age.
authors.affiliation: University of Cincinnati, Cincinnati, OH 45267, USA.
authors.forename: Muslim
authors.initials: M
authors.lastname: Atiq
authors.forename: Norah J
authors.initials: NJ
authors.lastname: Shire
authors.forename: Anna
authors.initials: A
authors.lastname: Barrett
authors.forename: Susan D
authors.initials: SD
authors.lastname: Rouster
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Sherman
authors.forename: Mohamed T
authors.initials: MT
authors.lastname: Shata
mesh_terms: D000328:Adult; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D005260:Female; D006508:Hepatitis Antibodies / Q000097:blood*; D016751:Hepatitis E / Q000453:epidemiology* / Q000821:virology; D016752:Hepatitis E virus / Q000276:immunology*; D006801:Humans; D008107:Liver Diseases / Q000453:epidemiology* / Q000276:immunology / Q000821:virology; D008297:Male; D008875:Middle Aged; D009820:Ohio / Q000453:epidemiology; D012307:Risk Factors; D016036:Seroepidemiologic Studies
chemical_list: D006508:Hepatitis Antibodies